Literature DB >> 18227967

High incidence of subclinical infection of lymphoid tissues in scrapie-affected sheep flocks.

Gudmundur Georgsson1, Jona Adalheidur Adolfsdottir, Astridur Palsdottir, Einar Jorundsson, Sigurdur Sigurdarson, Stefania Thorgeirsdottir.   

Abstract

Prion diseases are characterized by a long incubation period. In scrapie, sheep may incubate and spread the infection for several years before clinical signs evolve. We have previously studied the occurrence of subclinical infection in the brain. Now, we have studied the occurrence of subclinical infection in the brain and several lymphoid tissues in two scrapie-affected Icelandic sheep flocks by immunohistochemistry for PrP(Sc), a molecular marker for infectivity, and correlated this with results of PrP genotyping. At culling, one flock had one confirmed scrapie case, while the other flock had two. Analysis of 106 asymptomatic sheep by immunostaining for PrP(Sc) revealed that the incidence of subclinical infection was 58.3% in one flock and 42.5% in the other. PrP(Sc) was only detected in lymphoid tissues. The youngest positive sheep were 4 months old. PrP genotyping showed that over 90% of the sheep were of a genotype which is moderately sensitive to infection and may delay neuroinvasion. Our results show that asymptomatic sheep may spread the infection during the long incubation period of several years, which constitutes an important obstacle in the eradication of scrapie. Our findings indicate that contamination of the environment plays an important part in sustaining the infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227967     DOI: 10.1007/s00705-008-0035-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  In vitro amplification of prions from milk in the detection of subclinical infections.

Authors:  Kevin C Gough; Claire A Baker; Maged Taema; Ben C Maddison
Journal:  Prion       Date:  2009-10-23       Impact factor: 3.931

2.  Prion shedding from olfactory neurons into nasal secretions.

Authors:  Richard A Bessen; Harold Shearin; Scott Martinka; Ryan Boharski; Diana Lowe; Jason M Wilham; Byron Caughey; James A Wiley
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

3.  Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers.

Authors:  Hedok Lee; Hanna Rosenmann; Joab Chapman; Peter B Kingsley; Chen Hoffmann; Oren S Cohen; Esther Kahana; Amos D Korczyn; Isak Prohovnik
Journal:  Brain       Date:  2009-03-24       Impact factor: 13.501

4.  The evaluation of exposure risks for natural transmission of scrapie within an infected flock.

Authors:  Glenda Dexter; Sue C Tongue; Lindsay Heasman; Susan J Bellworthy; Andrew Davis; S Jo Moore; Marion M Simmons; A Robin Sayers; Hugh A Simmons; Danny Matthews
Journal:  BMC Vet Res       Date:  2009-10-09       Impact factor: 2.741

5.  Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters.

Authors:  Richard A Bessen; Cameron J Robinson; Davis M Seelig; Christopher P Watschke; Diana Lowe; Harold Shearin; Scott Martinka; Alex M Babcock
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

6.  Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey.

Authors:  O Noel Gill; Yvonne Spencer; Angela Richard-Loendt; Carole Kelly; Reza Dabaghian; Lynnette Boyes; Jacqueline Linehan; Marion Simmons; Paul Webb; Peter Bellerby; Nick Andrews; David A Hilton; James W Ironside; Jon Beck; Mark Poulter; Simon Mead; Sebastian Brandner
Journal:  BMJ       Date:  2013-10-15

7.  Expression of selected genes isolated from whole blood, liver and obex in lambs with experimental classical scrapie and healthy controls, showing a systemic innate immune response at the clinical end-stage.

Authors:  Siv Meling; Kerstin Skovgaard; Kjetil Bårdsen; Peter Mikael Helweg Heegaard; Martha J Ulvund
Journal:  BMC Vet Res       Date:  2018-09-12       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.